Lung cancer: Using ctDNA to track EGFR and KRAS mutations in advanced-stage disease
Rafael Rosell1, Niki Karachaliou2,3
1Catalan Institute of Oncology, Cancer Biology &Precision Medicine Programme, Germans Trias i Pujol Hospital and Health Sciences Institute, Campus Can Ruti, Carretera de Can Ruti, Cami de les Escoles S/N, Badalona, Barcelona 08916, Spain.
Nature Reviews. Clinical Oncology
|June 2, 2016
Abstract
No abstract available in PubMed .


